325 related articles for article (PubMed ID: 24144642)
1. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
[TBL] [Abstract][Full Text] [Related]
4. Tearing RAGs apart.
Gaspar HB
Blood; 2014 Jan; 123(2):156-7. PubMed ID: 24408206
[TBL] [Abstract][Full Text] [Related]
5. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
6. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
Inoue K; Miyamoto S; Tomomasa D; Adachi E; Azumi S; Horikoshi Y; Ishihara T; Osone S; Kawahara Y; Kudo K; Kato Z; Ohnishi H; Kashimada K; Imai K; Ohara O; van Zelm MC; Cowan MJ; Morio T; Kanegane H
J Clin Immunol; 2023 Apr; 43(3):585-594. PubMed ID: 36385359
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
[TBL] [Abstract][Full Text] [Related]
11. Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?
Cowan MJ; Gennery AR
J Allergy Clin Immunol; 2015 Nov; 136(5):1178-85. PubMed ID: 26055221
[TBL] [Abstract][Full Text] [Related]
12. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
[TBL] [Abstract][Full Text] [Related]
13. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
Lev A; Simon AJ; Bareket M; Bielorai B; Hutt D; Amariglio N; Rechavi G; Somech R
PLoS One; 2012; 7(1):e30494. PubMed ID: 22295088
[TBL] [Abstract][Full Text] [Related]
15. Successful TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for a Patient With Artemis Deficiency.
Tomomasa D; Isoda T; Mitsuiki N; Inoue K; Nishimura A; Uda K; Uchiyama T; Yamashita M; Kamiya T; Endo A; Takagi M; Imai K; Kajiwara M; Cowan MJ; Morio T; Kanegane H
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e285-e289. PubMed ID: 36757045
[TBL] [Abstract][Full Text] [Related]
16. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
17. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M; Kapoor N; Abdel-Azim H; Hanson IC; Martinez C; Bleesing JJH; Chandra S; Smith AR; Cavanaugh ME; Jyonouchi S; Sullivan KE; Burroughs L; Skoda-Smith S; Haight AE; Tumlin AG; Quigg TC; Taylor C; Dávila Saldaña BJ; Keller MD; Seroogy CM; Desantes KB; Petrovic A; Leiding JW; Shyr DC; Decaluwe H; Teira P; Gillio AP; Knutsen AP; Moore TB; Kletzel M; Craddock JA; Aquino V; Davis JH; Yu LC; Cuvelier GDE; Bednarski JJ; Goldman FD; Kang EM; Shereck E; Porteus MH; Connelly JA; Fleisher TA; Malech HL; Shearer WT; Szabolcs P; Thakar MS; Vander Lugt MT; Heimall J; Yin Z; Pulsipher MA; Pai SY; Kohn DB; Puck JM; Cowan MJ; O'Reilly RJ; Notarangelo LD
Blood; 2018 Oct; 132(17):1737-1749. PubMed ID: 30154114
[TBL] [Abstract][Full Text] [Related]
18. DNA-PKcs deficiency in human: long predicted, finally found.
van der Burg M; van Dongen JJ; van Gent DC
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):503-9. PubMed ID: 19823081
[TBL] [Abstract][Full Text] [Related]
19. A non-leaky Artemis-deficient mouse that accurately models the human severe combined immune deficiency phenotype, including resistance to hematopoietic stem cell transplantation.
Xiao Z; Dunn E; Singh K; Khan IS; Yannone SM; Cowan MJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):1-11. PubMed ID: 19135937
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral Gene Therapy for Artemis-Deficient SCID.
Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]